Yoon pushes for Xi’s visit to firm up ties with China
Esports legend Faker seeks to lead Korean surge at Asian Games
Incheon Airport passenger traffic to recover during Chuseok holiday
[Hello Hangeul] The making of Korean language textbooks featuring BTS
Korea’s parental leave benefits lag behind OECD average
Seoul prepares for first major military parade in ten years
Korea trade volume sees sharp drop among OECD members
2m Koreans opt out of life-extending treatments
[Korea Beyond Korea] Early Koreanists 'on verge of extinction overseas'
Chief justice seat at top court left vacant amid Assembly chaos
Shinhan Investment partners UK advisory firm to support bio firms’ overseas entryBy Choi Jae-hee
Published : Nov. 15, 2021 - 14:00
Under the partnership agreement, the two companies will boost cooperation in supporting South Korean biotech and pharmaceutical companies to advance to the global stage, while arranging international firms’ investments in the domestic health care market.
“We will provide differentiated IB services to help large and midsized bio firms to successfully make inroads into the global market,” said Jung Keun-soo, vice president and managing director of Shinhan Investment’s global investment banking division.
“In the coming year, (Shinhan Investment) will continue to carry out meaningful capital markets businesses to boost future growth industries.”
Founded in 1992, PharmaVentures handled more than 1,000 cases of mergers, acquisitions and joint venture activities for companies worldwide.
Opposition leader Lee attends arrest warrant hearing at Seoul court
Yoon says S. Korea-US alliance will end NK regime in event of nuclear weapons use
Blinken says N. Korea-Russia military cooperation threatens global peace